MARKET TRENDS
19 Mar 2026
INSIGHTS
16 Mar 2026
PARTNERSHIPS
10 Mar 2026
INNOVATION
20 Feb 2026

REGULATORY
12 Feb 2026
Draft guidance signals tougher standards for mRNA vaccines and a shift toward long-term regulatory rigor

INNOVATION
9 Aug 2025
Preclinical antibody-guided delivery suggests mRNA could move beyond vaccines toward more precise cancer and immune therapies

TECHNOLOGY
2 Aug 2025
Peer-reviewed research shows redesigned lipid nanoparticles can reduce toxicity without sacrificing delivery, fueling growing expert inter...

INVESTMENT
18 Jun 2025
BioNTech’s all-share purchase of CureVac sharpens Europe’s focus on mRNA therapies beyond Covid-19

RESEARCH
11 Jun 2025
European scientists are sharpening personalized mRNA cancer vaccines, with steady gains in design, delivery, and early clinical testing

REGULATORY
2 Apr 2025
New EMA draft guidance clarifies standards for mRNA vaccines, prompting cautious interest across Europe
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.